Related references
Note: Only part of the references are listed.Autologous stem-cell transplantation in patients with mantle cell lymphoma beyond 65 years of age: a study from the European Group for Blood and Marrow Transplantation (EBMT)
E. Jantunen et al.
ANNALS OF ONCOLOGY (2012)
Results From a Pivotal, Open-Label, Phase II Study of Romidepsin in Relapsed or Refractory Peripheral T-Cell Lymphoma After Prior Systemic Therapy
Bertrand Coiffier et al.
JOURNAL OF CLINICAL ONCOLOGY (2012)
Allogeneic transplantation following a reduced-intensity conditioning regimen in relapsed/refractory peripheral T-cell lymphomas: long-term remissions and response to donor lymphocyte infusions support the role of a graft-versus-lymphoma effect
A. Dodero et al.
LEUKEMIA (2012)
Treatment of Older Patients with Mantle-Cell Lymphoma
H. C. Kluin-Nelemans et al.
NEW ENGLAND JOURNAL OF MEDICINE (2012)
An international phase II trial of single-agent lenalidomide for relapsed or refractory aggressive B-cell non-Hodgkin's lymphoma
T. E. Witzig et al.
ANNALS OF ONCOLOGY (2011)
Mantle cell lymphoma: biology, pathogenesis, and the molecular basis of treatment in the genomic era
Patricia Perez-Galan et al.
BLOOD (2011)
Long-term outcomes after hematopoietic SCT for adult T-cell leukemia/lymphoma: results of prospective trials
I. Choi et al.
BONE MARROW TRANSPLANTATION (2011)
Mantle cell lymphoma: The promise of new treatment options
Andre Goy et al.
CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY (2011)
Indolent mantle cell leukemia: a clinicopathological variant characterized by isolated lymphocytosis, interstitial bone marrow involvement, kappa light chain restriction, and good prognosis
Sarah L. Ondrejka et al.
HAEMATOLOGICA-THE HEMATOLOGY JOURNAL (2011)
Peripheral T cell lymphomas with follicular T helper phenotype: a new basket or a distinct entity? Revising Karl Lennert's personal archive
Claudio Agostinelli et al.
HISTOPATHOLOGY (2011)
Mantle Cell Lymphoma International Prognostic Index but Not Pretransplantation Induction Regimen Predicts Survival for Patients With Mantle-Cell Lymphoma Receiving High-Dose Therapy and Autologous Stem-Cell Transplantation
Lihua E. Budde et al.
JOURNAL OF CLINICAL ONCOLOGY (2011)
Bortezomib Plus CHOP-Rituximab for Previously Untreated Diffuse Large B-Cell Lymphoma and Mantle Cell Lymphoma
Jia Ruan et al.
JOURNAL OF CLINICAL ONCOLOGY (2011)
Pralatrexate in Patients With Relapsed or Refractory Peripheral T-Cell Lymphoma: Results From the Pivotal PROPEL Study
Owen A. O'Connor et al.
JOURNAL OF CLINICAL ONCOLOGY (2011)
Temsirolimus and rituximab in patients with relapsed or refractory mantle cell lymphoma: a phase 2 study
Stephen M. Ansell et al.
LANCET ONCOLOGY (2011)
Lenalidomide monotherapy for relapsed/refractory peripheral T-cell lymphoma not otherwise specified
Pier Luigi Zinzani et al.
LEUKEMIA & LYMPHOMA (2011)
Allogeneic hematopoietic stem cell transplantation for advanced extranodal natural killer/T-cell lymphoma, nasal type
Daisuke Ennishi et al.
LEUKEMIA & LYMPHOMA (2011)
The complex landscape of genetic alterations in mantle cell lymphoma
Cristina Royo et al.
SEMINARS IN CANCER BIOLOGY (2011)
Treatment of Elderly Patients With Mantle Cell Lymphoma
Hanneke C. Kluin-Nelemans et al.
SEMINARS IN HEMATOLOGY (2011)
Treatment of Younger Patients With Mantle Cell Lymphoma
Stephanie Harel et al.
SEMINARS IN HEMATOLOGY (2011)
Significant efficacy of 2-CdA with or without rituximab in the treatment of splenic marginal zone lymphoma (SMZL)
G. Cervetti et al.
ANNALS OF ONCOLOGY (2010)
Outcome following Reduced-Intensity Allogeneic Stem Cell Transplantation (RIC AlloSCT) for Relapsed and Refractory Mantle Cell Lymphoma (MCL): A Study of the British Society for Blood and Marrow Transplantation
Gordon Cook et al.
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION (2010)
The Mantle Cell Lymphoma International Prognostic Index (MIPI) is superior to the International Prognostic Index (IPI) in predicting survival following intensive first-line immunochemotherapy and autologous stem cell transplantation (ASCT)
Christian H. Geisler et al.
BLOOD (2010)
Molecular remission is an independent predictor of clinical outcome in patients with mantle cell lymphoma after combined immunochemotherapy: a European MCL intergroup study
Christiane Pott et al.
BLOOD (2010)
Molecular signatures to improve diagnosis in peripheral T-cell lymphoma and prognostication in angioimmunoblastic T-cell lymphoma
Javeed Iqbal et al.
BLOOD (2010)
Pathway discovery in mantle cell lymphoma by integrated analysis of high-resolution gene expression and copy number profiling
Elena M. Hartmann et al.
BLOOD (2010)
Treatment and prognosis of mature T-cell and NK-cell lymphoma: an analysis of patients with T-cell lymphoma treated in studies of the German High-Grade Non-Hodgkin Lymphoma Study Group
Norbert Schmitz et al.
BLOOD (2010)
Phase II trial of zanolimumab (HuMax-CD4) in relapsed or refractory non-cutaneous peripheral T cell lymphoma
Francesco d'Amore et al.
BRITISH JOURNAL OF HAEMATOLOGY (2010)
Interim Report of A Phase 2 Clinical Trial of Lenalidomide for T-Cell Non-Hodgkin Lymphoma
Greg Dueck et al.
CANCER (2010)
Genomic and Gene Expression Profiling Defines Indolent Forms of Mantle Cell Lymphoma
Veronica Fernandez et al.
CANCER RESEARCH (2010)
Therapeutic concepts in mantle cell lymphoma
Jose Rodriguez et al.
EUROPEAN JOURNAL OF HAEMATOLOGY (2010)
A novel subset of T-helper cells: follicular T-helper cells and their markers
Camille Laurent et al.
HAEMATOLOGICA-THE HEMATOLOGY JOURNAL (2010)
Validation, revision and extension of the Mantle Cell Lymphoma International Prognostic Index in a population-based setting
Saskia A. M. van de Schans et al.
HAEMATOLOGICA-THE HEMATOLOGY JOURNAL (2010)
Front-line treatment of mantle cell lymphoma
Christian H. Geisler
HAEMATOLOGICA-THE HEMATOLOGY JOURNAL (2010)
Combination of rituximab with chlorambucil as first line treatment in patients with mantle cell lymphoma: a highly effective regimen
Sotirios Sachanas et al.
LEUKEMIA & LYMPHOMA (2010)
Bortezomib in patients with relapsed or refractory mantle cell lymphoma: updated time-to-event analyses of the multicenter phase 2 PINNACLE study
A. Goy et al.
ANNALS OF ONCOLOGY (2009)
The International Prognostic Index predicts outcome in aggressive adult T-cell leukemia/lymphoma: analysis of 126 patients from the International Peripheral T-cell Lymphoma Project
J. Suzumiya et al.
ANNALS OF ONCOLOGY (2009)
Long-term outcome following Helicobacter pylori eradication in a retrospective study of 105 patients with localized gastric marginal zone B-cell lymphoma of MALT type
A. Stathis et al.
ANNALS OF ONCOLOGY (2009)
Allogeneic Stem Cell Transplantation for Patients with Relapsed Chemorefractory Aggressive Non-Hodgkin Lymphomas
Mehdi Hamadani et al.
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION (2009)
Mature results of the M. D. Anderson Cancer Center risk-adapted transplantation strategy in mantle cell lymphoma
Constantine S. Tam et al.
BLOOD (2009)
Strong lymphoid nuclear expression of SOX11 transcription factor defines lymphoblastic neoplasms, mantle cell lymphoma and Burkitt's lymphoma
Michael Dictor et al.
HAEMATOLOGICA-THE HEMATOLOGY JOURNAL (2009)
SOX11 expression is highly specific for mantle cell lymphoma and identifies the cyclin D1-negative subtype
Ana Mozos et al.
HAEMATOLOGICA-THE HEMATOLOGY JOURNAL (2009)
Improvement of Overall Survival in Advanced Stage Mantle Cell Lymphoma
Annina Herrmann et al.
JOURNAL OF CLINICAL ONCOLOGY (2009)
Pre-Emptive Treatment With Rituximab of Molecular Relapse After Autologous Stem Cell Transplantation in Mantle Cell Lymphoma
Niels S. Andersen et al.
JOURNAL OF CLINICAL ONCOLOGY (2009)
Allogeneic Stem Cell Transplantation Is Able to Induce Long-Term Remissions in Angioimmunoblastic T-Cell Lymphoma: A Retrospective Study From the Lymphoma Working Party of the European Group for Blood and Marrow Transplantation
Charalampia Kyriakou et al.
JOURNAL OF CLINICAL ONCOLOGY (2009)
Phase III Study to Evaluate Temsirolimus Compared With Investigator's Choice Therapy for the Treatment of Relapsed or Refractory Mantle Cell Lymphoma
Georg Hess et al.
JOURNAL OF CLINICAL ONCOLOGY (2009)
Follicular Lymphoma International Prognostic Index 2: A New Prognostic Index for Follicular Lymphoma Developed by the International Follicular Lymphoma Prognostic Factor Project
Massimo Federico et al.
JOURNAL OF CLINICAL ONCOLOGY (2009)
The simplified mantle cell lymphoma international prognostic index predicts overall survival but not progression-free survival in patients with mantle cell lymphoma treated with fludarabine and cyclophosphamide +/- rituximab: results of a randomized phase II trial
Heather E. Eve et al.
LEUKEMIA & LYMPHOMA (2009)
A novel regimen combining high dose cytarabine and bortezomib has activity in multiply relapsed and refractory mantle cell lymphoma - long-term results of a multicenter observation study
Oliver Weigert et al.
LEUKEMIA & LYMPHOMA (2009)
Hemopoietic stem cell transplantation in T-cell malignancies: Who, when, and how?
Francesco d’Amore et al.
Current Hematologic Malignancy Reports (2009)
Current treatment standards and emerging strategies in mantle cell lymphoma
M. Dreyling et al.
Hematology-American Society of Hematology Education Program (2009)
Allogeneic transplantation with reduced-intensity conditioning for Hodgkin and non-Hodgkin lymphoma: Importance of histology for outcome
Philippe Armand et al.
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION (2008)
Mantle Cell International Prognostic Index (MIPI) not prognostic after R-hyper-CVAD
Jatin J. Shah et al.
BLOOD (2008)
ALK-anaplastic large-cell lymphoma is clinically and immunophenotypically different from both ALK+ ALCL and peripheral T-cell lymphoma, not otherwise specified:: report from the International Peripheral T-Cell Lymphoma Project
Kerry J. Savage et al.
BLOOD (2008)
Long-term progression-free survival of mantle cell lymphoma after intensive front-line immunochemotherapy with in vivo-purged stem cell rescue:: a nonrandomized phase 2 multicenter study by the Nordic Lymphoma Group
Christian H. Geisler et al.
BLOOD (2008)
A new prognostic index (MIPI) for patients with advanced-stage mantle cell lymphoma
Eva Hoster et al.
BLOOD (2008)
Advances in the understanding of mantle cell lymphoma
Pedro Jares et al.
BRITISH JOURNAL OF HAEMATOLOGY (2008)
High-grade transformation in splenic marginal zone lymphoma with circulating villous lymphocytes: the site of transformation influences response to therapy and prognosis
M. Dungarwalla et al.
BRITISH JOURNAL OF HAEMATOLOGY (2008)
Low-dose, single-agent temsirolimus for relapsed mantle cell lymphoma - A phase 2 trial in the North Central Cancer Treatment Group
Stephen M. Ansell et al.
CANCER (2008)
Mantle cell lymphoma with aberrant expression of CD10
U. Zanetto et al.
HISTOPATHOLOGY (2008)
Five-Gene Model to Predict Survival in Mantle-Cell Lymphoma Using Frozen or Formalin-Fixed, Paraffin-Embedded Tissue
Elena Hartmann et al.
JOURNAL OF CLINICAL ONCOLOGY (2008)
International peripheral T-cell and natural killer/T-cell lymphoma study: Pathology findings and clinical outcomes
Julie M. Vose et al.
JOURNAL OF CLINICAL ONCOLOGY (2008)
Ki-67 predicts outcome in advanced-stage mantle cell lymphoma patients treated with anti-CD20 immunochemotherapy: results from randomized trials of the European MCL Network and the German Low Grade lymphoma Study Group
Olaf Determann et al.
BLOOD (2008)
Splenic marginal zone lymphoma proposals for a revision of diagnostic, staging and therapeutic criteria
E. Matutes et al.
LEUKEMIA (2008)
Most patients with minimal histological residuals of gastric MALT lymphoma after successful eradication of Helicobacter pylori can be managed safely by a watch and wait strategy:: experience from a large international series
W. Fischbach et al.
GUT (2007)
Allogeneic stem cell transplantation following reduced-intensity conditioning can induce durable clinical and molecular remissions in relapsed lymphomas: pre-transplant disease status and histotype heavily influence outcome
P. Corradini et al.
LEUKEMIA (2007)
Genetic and molecular pathogenesis of mantle cell lymphoma: perspectives for new targeted therapeutics
Pedro Jares et al.
NATURE REVIEWS CANCER (2007)
Alemtuzumab (Campath-1H) and CHOP chemotherapy as first-line treatment of peripheral T-cell lymphoma: results of a GITIL (Grappo Italiano Terapie Innovative nei Linfomi) prospective multicenter trial
Andrea Gallamini et al.
BLOOD (2007)
Phase II trial of proteasome inhibitor bortezomib in patients with relapsed or refractory cutaneous T-cell lymphoma
Pier Luigi Zinzani et al.
JOURNAL OF CLINICAL ONCOLOGY (2007)
The role of high-dose therapy and stem cell rescue in the management of T-cell malignant lymphomas: a BSBMT and ABMTRR study
S. Feyler et al.
BONE MARROW TRANSPLANTATION (2007)
Autologous hematopoietic stem cell transplantation in peripheral T-cell lymphoma using a uniform high-dose regimen
S. D. Smith et al.
BONE MARROW TRANSPLANTATION (2007)
The adjusted International Prognostic Index and β-2-microglobulin predict the outcome after autologous stem cell transplantation in relapsing/refractory peripheral T-cell lymphoma
Jose Rodriguez et al.
HAEMATOLOGICA (2007)
Identification of a proliferation signature related to survival in nodal peripheral T-cell lymphomas
Marta Cuadros et al.
JOURNAL OF CLINICAL ONCOLOGY (2007)
Quantitative gene expression deregulation in mantle-cell lymphoma:: Correlation with clinical and biologic factors
Dirk Kienle et al.
JOURNAL OF CLINICAL ONCOLOGY (2007)
High-dose chemotherapy and autologous stem cell transplantation for peripheral T-cell lymphoma: complete response at transplant predicts survival
Min Kyoung Kim et al.
ANNALS OF HEMATOLOGY (2007)
Immunochemotherapy with rituximab and overall survival in patients with indolent or mantle cell lymphoma: A systematic review and meta-analysis
Holger Schulz et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2007)
Specific secondary genetic alterations in mantle cell lymphoma provide prognostic information independent of the gene expression-based proliferation signature
Itziar Salaverria et al.
JOURNAL OF CLINICAL ONCOLOGY (2007)
The results of consolidation with autologous stem-cell transplantation in patients with peripheral T-cell lymphoma (PTCL) in first complete remission:: the Spanish Lymphoma and Autologous Transplantation Group experience
J. Rodriguez et al.
ANNALS OF ONCOLOGY (2007)
Immunohistochemical prognostic markers in diffuse large B-cell lymphoma: Validation of tissue microarray as a prerequisite for broad clinical applications - A study from the Lunenburg Lymphoma Biomarker Consortium
Daphne de Jong et al.
JOURNAL OF CLINICAL ONCOLOGY (2007)
Powerful strategy for polymerase chain reaction-based clonality assessment in T-cell malignancies Report of the BIOMED-2 Concerted Action BHM4 CT98-3936
M. Brueggemann et al.
LEUKEMIA (2007)
Prevalence of HCV infection in nongastric marginal zone B-cell lymphoma of MALT
L. Arcaini et al.
ANNALS OF ONCOLOGY (2007)
Gemcitabine, cisplatin and methylprednisolone for the treatment of patients with peripheral T-cell lymphoma: the Royal Marsden Hospital experience
Hendrik-Tobias Arkenau et al.
HAEMATOLOGICA (2007)
Results of a phase II study of 506U78 in cutaneous T-cell lymphoma and peripheral T-cell lymphoma: CALGB 59901
Myron S. Czuczman et al.
LEUKEMIA & LYMPHOMA (2007)
Rituximab monotherapy is highly effective in splenic marginal zone lymphoma
C. Kalpadakis et al.
HEMATOLOGICAL ONCOLOGY (2007)
Heterogeneous CD52 expression among hematologic neoplasms: Implications for the use of alemtuzumab (CAMPATH-1H)
Scott J. Rodig et al.
CLINICAL CANCER RESEARCH (2006)
Comparison of reduced-intensity and conventional myeloablative regimens for allogeneic transplantation in non-Hodgkin's lymphoma
Roberto Rodriguez et al.
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION (2006)
Rituximab induces effective clearance of minimal residual disease in molecular relapses of mantle cell lymphoma
Marco Ladetto et al.
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION (2006)
Combined cyclophosphamide, vincristine, doxorubicin, and prednisone (CHOP) improves response rates but not survival and has lower hematologic toxicity compared with combined mitoxantrone, chlorambucil, and prednisone (MCP) in follicular and mantle cell lymphomas - Results of a prospective randomized trial of the German Low-Grade Lymphoma Study Group
Christina Nickenig et al.
CANCER (2006)
Outcomes in patients with splenic marginal zone lymphoma and marginal zone lymphoma treated with rituximab with or without chemotherapy or chemotherapy alone
Apostolia M. Tsimberidou et al.
CANCER (2006)
Assessment of disease dissemination in gastric compared with extragastric mucosa-associated lymphoid tissue lymphoma using extensive staging:: A single-center experience
Markus Raderer et al.
JOURNAL OF CLINICAL ONCOLOGY (2006)
Efficacy of high-dose therapy and hematopoietic stem cell transplantation for mantle cell lymphoma
Noel Laudi et al.
AMERICAN JOURNAL OF HEMATOLOGY (2006)
Autologous transplantation for relapsed or primary refractory peripheral T-cell lymphoma
Tarun Kewalramani et al.
BRITISH JOURNAL OF HAEMATOLOGY (2006)
Splenic marginal zone lymphoma: a prognostic model for clinical use
Luca Arcaini et al.
BLOOD (2006)
Marker expression in peripheral T-cell lymphoma: A proposed clinical-pathologic prognostic score
Philip Went et al.
JOURNAL OF CLINICAL ONCOLOGY (2006)
Mantle cell lymphoma: prognostic capacity of the Follicular Lymphoma International Prognostic Index
MB Moller et al.
BRITISH JOURNAL OF HAEMATOLOGY (2006)
Quantitative assessment of molecular remission after high-dose therapy with autologous stem cell transplantation predicts long-term remission in mantle cell lymphoma
C Pott et al.
BLOOD (2006)
A clinicopathological study of nodal marginal zone B-cell lymphoma. A report on 21 cases
A Traverse-Glehen et al.
HISTOPATHOLOGY (2006)
Cyclin D1-negative mantle cell lymphoma:: a clinicopathologic study based on gene expression profiling
K Fu et al.
BLOOD (2005)
Activity and safety of combined rituximab with chlorambucil in patients with mantle cell lymphoma
D Bauwens et al.
BRITISH JOURNAL OF HAEMATOLOGY (2005)
Histopathology, cell proliferation indices and clinical outcome in 304 patients with mantle cell lymphoma (MCL):: a clinicopathological study from the European MCL Network
M Tiemann et al.
BRITISH JOURNAL OF HAEMATOLOGY (2005)
Allogeneic haematopoietic stem-cell transplantation for relapsed and refractory aggressive histology non-Hodgkin lymphoma
RT Doocey et al.
BRITISH JOURNAL OF HAEMATOLOGY (2005)
Allogeneic haematopoietic stem cell transplantation as a promising treatment for natural killer-cell neoplasms
N Murashige et al.
BRITISH JOURNAL OF HAEMATOLOGY (2005)
Hematopoietic stem cell transplantation in mantle cell lymphoma
AK Ganti et al.
ANNALS OF ONCOLOGY (2005)
Early consolidation by myeloablative radiochemotherapy followed by autologous stem cell transplantation in first remission significantly prolongs progression-free survival in mantle-cell lymphoma: results of a prospective randomized trial of the European MCL Network
M Dreyling et al.
BLOOD (2005)
Immunochemotherapy with rituximab and cyclophosphamide, doxorubicin, vincristine, and prednisone significantly improves response and time to treatment failure, but not long-term outcome in patients with previously untreated mantle cell lymphoma:: Results of a prospective randomized trial of the German low grade lymphoma study group (GLSG)
G Lenz et al.
JOURNAL OF CLINICAL ONCOLOGY (2005)
CDK4 and MDM2 gene alterations mainly occur in highly proliferative and aggressive mantle cell lymphomas with wild-type INK4a/ARF locus
L Hernández et al.
CANCER RESEARCH (2005)
Allogeneic stem cell transplantation for mantle cell lymphoma - does it deserve a better look?
J Rifkind et al.
LEUKEMIA & LYMPHOMA (2005)
Effect of single-agent rituximab given at the standard schedule or as prolonged treatment in patients with mantle cell lymphoma: A study of the Swiss Group for Clinical Cancer Research (SAKK)
M Ghielmini et al.
JOURNAL OF CLINICAL ONCOLOGY (2005)
Outcomes of autologous and allogeneic blood or marrow transplantation for mantle cell lymphoma
YL Kasamon et al.
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION (2005)
A pilot study of alemtuzumab (anti-CD52 monoclonal antibody) therapy for patients with relapsed or chemotherapy-refractory peripheral T-cell lymphomas
G Enblad et al.
BLOOD (2004)
Peripheral T-cell lymphoma unspecified (PTCL-U): a new prognostic model from a retrospective multicentric clinical study
A Gallamini et al.
BLOOD (2004)
Autologous stem cell transplantation in adult patients with peripheral T-cell lymphoma:: a nation-wide survey
E Jantunen et al.
BONE MARROW TRANSPLANTATION (2004)
Response to antiviral treatment in hepatitis C virus-associated marginal zone lymphomas
C Kelaidi et al.
LEUKEMIA (2004)
Follicular lymphoma international prognostic index
P Solal-Céligny et al.
BLOOD (2004)
Outcomes after alemtuzumab-containing reduced-intensity allogeneic transplantation regimen for relapsed and refractory non-Hodgkin lymphoma
E Morris et al.
BLOOD (2004)
Predominance of type 1 (Th1) cytokine production in the liver of patients with HCV-associated mixed cryoglobulinemia vasculitis
D Saadoun et al.
JOURNAL OF HEPATOLOGY (2004)
Allogeneic hematopoietic cell transplantation after fludarabine and 2 Gy total body irradiation for relapsed and refractory mantle cell lymphoma
MB Maris et al.
BLOOD (2004)
T-cell lymphoma as a model for the use of histone deacetylase inhibitors in cancer therapy: impact of depsipeptide on molecular markers, therapeutic targets, and mechanisms of resistance
RL Piekarz et al.
BLOOD (2004)
Rituximab consolidation after high-dose chemotherapy and autologous blood stem cell transplantation in follicular and mantle cell lymphoma:: a prospective, multicenter phase II study
W Brugger et al.
ANNALS OF ONCOLOGY (2004)
Splenic and nodal marginal zone lymphomas are indolent disorders at high hepatitis C virus seroprevalence with distinct presenting features but similar morphologic and phenotypic profiles
L Arcaini et al.
CANCER (2004)
Histology impacts the outcome of peripheral T-cell lymphomas after high dose chemotherapy and stem cell transplant
M Jagasia et al.
LEUKEMIA & LYMPHOMA (2004)
Graft-versus-lymphoma effect in relapsed peripheral T-cell non-Hodgkin's lymphomas after reduced-intensity conditioning followed by allogeneic transplantation of hematopoietic cells
P Corradini et al.
JOURNAL OF CLINICAL ONCOLOGY (2004)
Proposal for a new histological grading system for post-treatment evaluation of gastric MALT lymphoma
C Copie-Bergman et al.
GUT (2003)
Long-term remission in mantle cell lymphoma following high-dose sequential chemotherapy and in vivo rituximab-purged stem cell autografting (R-HDS regimen)
AM Gianni et al.
BLOOD (2003)
A subset of t(11;14) lymphoma with mantle cell features displays mutated IgVH genes and includes patients with good prognosis, nonnodal disease
J Orchard et al.
BLOOD (2003)
Nodal marginal zone lymphoma:: A heterogeneous tumor -: A comprehensive analysis of a series of 27 cases
FI Camacho et al.
AMERICAN JOURNAL OF SURGICAL PATHOLOGY (2003)
Nongastric marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue
E Zucca et al.
BLOOD (2003)
Autologous stem cell transplant for relapsed and refractory peripheral T-cell lymphoma: variable outcome according to pathological subtype
KW Song et al.
BRITISH JOURNAL OF HAEMATOLOGY (2003)
Prognostic features of splenic lymphoma with villous lymphocytes: a report on 129 patients
N Parry-Jones et al.
BRITISH JOURNAL OF HAEMATOLOGY (2003)
Splenic marginal-zone lymphoma: a distinct clinical and pathological entity
C Thieblemont et al.
LANCET ONCOLOGY (2003)
The proliferation gene expression signature is a quantitative integrator of oncogenic events that predicts survival in mantle cell lymphoma
A Rosenwald et al.
CANCER CELL (2003)
Nonablative allogeneic stem-cell transplantation for advanced/recurrent mantle-cell lymphoma
IF Khouri et al.
JOURNAL OF CLINICAL ONCOLOGY (2003)
Chemoresistant or aggressive lymphoma predicts for a poor outcome following reduced-intensity allogeneic progenitor cell transplantation: an analysis from the Lymphoma Working Party of the European Group for Blood and Bone Marrow Transplantation
SP Robinson et al.
BLOOD (2002)
Nonmyeloablative transplantation with or without alemtuzumab:: comparison between 2 prospective studies in patients with lymphoproliferative disorders
JA Pérez-Simón et al.
BLOOD (2002)
Regression of splenic lymphoma with villous lymphocytes after treatment of hepatitis C virus infection
O Hermine et al.
NEW ENGLAND JOURNAL OF MEDICINE (2002)
Treatment of splenic marginal zone B-cell lymphoma: An analysis of 81 patients
C Thieblemont et al.
CLINICAL LYMPHOMA (2002)
Progression to large B-cell lymphoma in splenic marginal zone lymphoma -: A description of a series of 12 cases
FI Camacho et al.
AMERICAN JOURNAL OF SURGICAL PATHOLOGY (2001)
High-dose therapy with autologous stem cell transplantation in patients with peripheral T cell lymphomas
AK Blystad et al.
BONE MARROW TRANSPLANTATION (2001)
Allogeneic bone marrow transplantation in patients with sensitive low-grade lymphoma or mantle cell lymphoma
JG Berdeja et al.
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION (2001)
Fludarabine:: an effective treatment in patients with splenic lymphoma with villous lymphocytes
F Lefrère et al.
LEUKEMIA (2000)
Share Paper
